| 1. Executive Summary |
| 2. Global Transplantation Market Introduction |
| 2.1. Global Transplantation Market – Taxonomy |
| 2.2. Global Transplantation Market –Definitions |
| 2.2.1. By Product Type |
| 2.2.2. By Application |
| 2.2.3. By End User |
| 2.2.4. By Region |
| 3. Global Transplantation Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Transplantation Market Dynamic Factors - Impact Analysis |
| 3.6. Global Transplantation Market – Competition Landscape |
| 4. Global Transplantation Market Analysis,2017-2021 and Forecast, 2022-2028 |
| 4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Transplantation Market, By Product Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1. Tissue products |
| 5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Immunosuppressive drugs |
| 5.2.1. Calcineurin Inhibitors |
| 5.2.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.1.3. Market Opportunity Analysis |
| 5.2.2. Antiproliferative Agents |
| 5.2.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.2.3. Market Opportunity Analysis |
| 5.2.3. mTOR inhibitor |
| 5.2.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3.3. Market Opportunity Analysis |
| 5.2.4. Steroids |
| 5.2.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.4.3. Market Opportunity Analysis |
| 6. Global Transplantation Market Forecast, By Application, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn) |
| 6.1. Organ transplantation |
| 6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Tissue transplantation |
| 6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Transplantation Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Transplantation Centers |
| 7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Transplantation Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific |
| 8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa |
| 8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Transplantation Market - Opportunity Analysis Index, By Product Type, Application, End User, and Region, 2022-2028 |
| 9. North America Transplantation MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.1. By Product Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Tissue products |
| 9.1.2. Immunosuppressive drugs |
| 9.1.2.1. Calcineurin Inhibitors |
| 9.1.2.2. Antiproliferative agents |
| 9.1.2.3. mTOR inhibitor |
| 9.1.2.4. Steroids |
| 9.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Organ transplantation |
| 9.2.2. Tissue transplantation |
| 9.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1. Hospitals |
| 9.3.2. Transplantation Centers |
| 9.3.3. Others |
| 9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.4.1. USA |
| 9.4.2. Canada |
| 9.5. North America Transplantation Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022-2028 |
| 9.6. North America Transplantation Market Dynamics – Trends |
| 10. Europe Transplantation Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 10.1. By Product Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Tissue products |
| 10.1.2. Immunosuppressive drugs |
| 10.1.2.1. Calcineurin Inhibitors |
| 10.1.2.2. Antiproliferative agents |
| 10.1.2.3. mTOR inhibitor |
| 10.1.2.4. Steroids |
| 10.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Organ transplantation |
| 10.2.2. Tissue transplantation |
| 10.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Hospitals |
| 10.3.2. Transplantation Centers |
| 10.3.3. Others |
| 10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Germany |
| 10.4.2. UK |
| 10.4.3. France |
| 10.4.4. Spain |
| 10.4.5. Italy |
| 10.4.6. Russia |
| 10.4.7. Poland |
| 10.4.8. Rest of Europe |
| 10.5. Europe Transplantation Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022-2028 |
| 10.6. Europe Transplantation Market Dynamics – Trends |
| 11. Asia-Pacific Transplantation Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 11.1. By Product Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Tissue products |
| 11.1.2. Immunosuppressive drugs |
| 11.1.2.1. Calcineurin Inhibitors |
| 11.1.2.2. Antiproliferative agents |
| 11.1.2.3. mTOR inhibitor |
| 11.1.2.4. Steroids |
| 11.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Organ transplantation |
| 11.2.2. Tissue transplantation |
| 11.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Hospitals |
| 11.3.2. Transplantation Centers |
| 11.3.3. Others |
| 11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Japan |
| 11.4.2. China |
| 11.4.3. India |
| 11.4.4. ASEAN |
| 11.4.5. Australia & New Zealand |
| 11.4.6. Rest of Asia-Pacific |
| 11.5. Asia-Pacific Transplantation Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022-2028 |
| 11.6. Asia-Pacific Transplantation Market Dynamics – Trends |
| 12. Latin America Transplantation Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 12.1. By Product Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Tissue products |
| 12.1.2. Immunosuppressive drugs |
| 12.1.2.1. Calcineurin Inhibitors |
| 12.1.2.2. Antiproliferative agents |
| 12.1.2.3. mTOR inhibitor |
| 12.1.2.4. Steroids |
| 12.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Organ transplantation |
| 12.2.2. Tissue transplantation |
| 12.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Hospitals |
| 12.3.2. Transplantation Centers |
| 12.3.3. Others |
| 12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Brazil |
| 12.4.2. Mexico |
| 12.4.3. Argentina |
| 12.4.4. Rest of Latin America |
| 12.5. Latin America Transplantation Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022-2028 |
| 12.6. Latin America Transplantation Market Dynamics – Trends |
| 13. Middle East and Africa Transplantation Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 13.1. By Product Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Tissue products |
| 13.1.2. Immunosuppressive drugs |
| 13.1.2.1. Calcineurin Inhibitors |
| 13.1.2.2. Antiproliferative agents |
| 13.1.2.3. mTOR inhibitor |
| 13.1.2.4. Steroids |
| 13.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Organ transplantation |
| 13.2.2. Tissue transplantation |
| 13.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1. Hospitals |
| 13.3.2. Transplantation Centers |
| 13.3.3. Others |
| 13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Gulf Cooperation Council (GCC) Countries |
| 13.4.2. Israel |
| 13.4.3. South Africa |
| 13.4.4. Rest of MEA |
| 13.5. MEA Transplantation Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022-2028 |
| 13.6. MEA Transplantation Market Dynamics – Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, Application& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Abbvie, Inc |
| 14.2.2. Arthrex, Inc. |
| 14.2.3. Zimmer Biomet |
| 14.2.4. Medtronic |
| 14.2.5. Novartis AG |
| 14.2.6. Strykers |
| 14.2.7. 21st Century Medicine |
| 14.2.8. BiolifeSolutions, Inc |
| 14.2.9. Teva Pharmaceuticals |
| 14.2.10. Veloxis Pharmaceutical |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
hghLatin America Got Significant Share
Transplantation Market
Latin America
Europe
Asia Pacific
Middle East
North America
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Key Features of the Report
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
- Abbvie, Inc
- Arthrex, Inc.
- Zimmer Biomet
- Medtronic
- ovartis AG
- Strykers
- 21st Century Medicine
- Â BiolifeSolutions, Inc
- Teva Pharmaceuticals
- Veloxis Pharmaceutical